Mondo Visione Worldwide Financial Markets Intelligence
Track all markets on TradingView

FTSE Mondo Visione Exchanges Index:

News Centre

MV 468 x 60 Your Brand Our Audience

  • Circular On Self-Regulatory Measures Taken By CFFEX In March 2022

    Date 12/04/2022

    To prevent market risks, maintain the orderly operation of the market and protect investors’ legitimate rights and interests, China Financial Futures Exchange (CFFEX) took the following self-regulatory measures against violations of exchange rules in March 2022.

  • Hong Kong Securities And Futures Commission Bans Poon Choi Yung For 20 Months

    Date 12/04/2022

    The Securities and Futures Commission (SFC) has banned Mr Poon Choi Yung, a former licensed representative of China Tonghai Securities Limited, from re-entering the industry for 20 months from 12 April 2022 to 11 December 2023 for breaches of the SFC’s Code of Conduct.

  • Shanghai Stock Exchange STAR Market Biomedicine Index To Be Released Soon

    Date 12/04/2022

    The “14th Five-year Plan” period has seen the accelerated formation of a new development paradigm featuring dual circulation, in which the domestic economic cycle plays a leading role while the international economic cycle remains its extension and supplement, and China’s biomedical market has ushered in a stage of high-quality development. Meanwhile, the new development stage has higher requirements on the biomedical industry, which finds it urgent to expedite the innovation-driven transformation so as to bolster the creation of the new development paradigm. Today, the Shanghai Stock Exchange (SSE) and the China Securities Index Co., Ltd. (CSI) officially announced the relevant arrangements for the release of the SSE STAR Market Biomedicine Index ( the STAR Market Biomedicine Index for short). After the screening for liquidity, the STAR Market Biomedicine Index is to include the stocks of 50 companies with large market capitalization in the biomedicine, biomedical engineering and other biological industries as index constituents. The 5 stocks with the largest weights are Shanghai Junshi Biosciences Co., Ltd., Zhejiang Orient Gene Biotech Co., Ltd., Cansino Biologics Inc., Shanghai Medicilon Inc. and Qingdao Haier Biomedical Co., Ltd., with a combined weight of 33%.

  • Focusing On Serving Key National Development Strategies, Shenzhen Stock Exchange Releases Four Indexes Concerning New Infrastructure, Carbon Neutral Bonds And New Chinese Products

    Date 12/04/2022

    On April 11, SZSE’s wholly-owned subsidiary Shenzhen Securities Information Co., Ltd. released four indexes, namely, SZSE New Infrastructure 50 Index, CNI CUFE Carbon Neutral Green Bond Index, CNI CUFE Carbon Neutral 50 Index, and CNI HK Connect New Chinese Products 50 Index. That has further enriched the index series with Shenzhen market characteristics, refined the green index system, and expanded the scope of targets tracked by index funds.

  • NYSE Group Consolidated Short Interest Report

    Date 11/04/2022

    NYSE today reported short interest as of the close of business on the settlement date of March 31, 2022.

MV 120 X 600 Hard to Reach